首页 正文

Anaplastic lymphoma kinase inhibitors as anticancer therapeutics: a patent review

{{output}}
Introduction: Anaplastic lymphoma kinase (ALK), a receptor tyrosine kinase from the insulin receptor superfamily, is implicated in the oncogenesis of numerous cancers including anaplastic large-cell lymphoma, non-small-cell lung ... ...